Medpace Holdings, Inc.
Health
Performance
5.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

Medpace Holdings, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

21.07.2026
From god-tier to top-tier. Still dominant, but no longer flawless.
30.06.2026
Signs of control returning. Still shaky, but not chaos.
24.06.2026
Outperforming hard. Momentum locked in.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.
MEDP
Medpace Holdings, Inc.
533.24
+1.01%
5.6
Sell
Buy
Medpace Holdings, Inc.

Medpace Holdings, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Medpace Holdings, Inc. do? Business model and key facts

Get the full picture of Medpace Holdings, Inc.: what it builds, where it operates, and how it makes money.

Medpace Holdings, Inc. Profile

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Employees (FY): 6200

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

shop
Company facts
August James Troendle
CEO
6200
Employees worldwide
shop
Performance
70.92%
Last 12 months
187.62%
Last 5 years
shop
Growth
$2.53B
Revenue year
$451.12M
Net income
shop
Valuation
$15.36B
Market Cap
35.91
Price/Earnings Ratio

Stocks related to Medpace Holdings, Inc.

Selected based on industry alignment and relative market positioning.

EXAS
Exact Sciences Corporation
104.91
+0.00%
5.9
Sell
Buy
Exact Sciences Corporation
GH
Guardant Health, Inc.
152.17
+2.77%
8.2
Sell
Buy
Guardant Health, Inc.
LH
Labcorp Holdings Inc.
279.46
-0.72%
2.2
Sell
Buy
Labcorp Holdings Inc.
ICLR
ICON Public Limited Company
165.63
-0.33%
7.7
Sell
Buy
ICON Public Limited Company
RVTY
Revvity, Inc.
109.99
+3.33%
4.5
Sell
Buy
Revvity, Inc.

Events and news impacting Medpace Holdings, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Medpace Holdings, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.